Índice

• • ·Smoking cessation in patients with coronary artery disease

    Página :565-572

    Jason Ludvig, Brienne Miner, Mark J. Eisenberg

    Resumen Resumen Esquema Esquema  
• • ·Change of Address Box

    Página :572

    
• • ·Cardioprotection before revascularization in ischemic myocardial injury and the potential role of hemoglobin-based oxygen carriers

    Página :573-579

    Daniel Burkhoff, David J. Lefer

    Resumen Resumen Esquema Esquema  
• • ·Attenuation of reperfusion microvascular ischemia by aqueous oxygen: Experimental and clinical observations

    Página :580-584

    James J. Glazier

    Resumen Resumen Esquema Esquema
• • ·Glucose-insulin-potassium and reperfusion in acute myocardial infarction: Rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2)

    Página :585-591

    Iwan C.C. van der Horst, Jorik R. Timmer, Jan Paul Ottervanger, Henk J.G. Bilo, Rijk O.B. Gans, Menko-Jan de Boer, Felix Zijlstra, on behalf of the GIPS Investigators

    Resumen Resumen Esquema Esquema  
• • ·INvestigation of STEnt grafts in patients with type B Aortic Dissection: Design of the INSTEAD trial—a prospective, multicenter, European randomized trial

    Página :592-599

    Christoph A. Nienaber, Simona Zannetti, Barbara Barbieri, Stephan Kische, Wolfgang Schareck, Tim C. Rehders, on behalf of the INSTEAD study collaborators 1

    Resumen Resumen Esquema Esquema  
• • ·Predictors of response to cardiac resynchronization therapy (PROSPECT)—study design

    Página :600-605

    Cheuk-Man Yu, William T. Abraham, Jeroen Bax, Eugene Chung, Michelle Fedewa, Stefano Ghio, Christophe Leclercq, Angel R. León, John Merlino, Petros Nihoyannopoulos, Dean Notabartolo, Jing Ping Sun, Luigi Tavazzi, On behalf of the PROSPECT Investigators

    Resumen Resumen Esquema Esquema
• • ·Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study

    Página :606-612

    Keattiyoat Wattanakit, Aaron R. Folsom, Lloyd E. Chambless, F. Javier Nieto

    Resumen Resumen Esquema Esquema
• • ·Are we appropriately triaging patients with unstable angina?

    Página :613-618

    Mardi Gomberg-Maitland, Sabina A. Murphy, David J. Moliterno, Christopher P. Cannon

    Resumen Resumen Esquema Esquema  
• • ·An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease

    Página :619-626

    Stefan K. James, Jonas Oldgren, Johan Lindbäck, Nina Johnston, Agneta Siegbahn, Lars Wallentin

    Resumen Resumen Esquema Esquema  
• • ·Prevalence of metabolic syndrome in cardiac rehabilitation/secondary prevention programs

    Página :627-631

    Patrick D. Savage, John A. Banzer, Gary J. Balady, Philip A. Ades

    Resumen Resumen Esquema Esquema  
• • ·Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus

    Página :632-636

    Matjaz Vrtovec, Bojan Vrtovec, Alenka Briski, Andreja Kocijancic, Richard A. Anderson, Branislav Radovancevic

    Resumen Resumen Esquema Esquema  
• • ·Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: Costs of reperfusion strategies in acute myocardial infarction

    Página :637-644

    Padma Kaul, Paul W. Armstrong, Patricia A. Cowper, Eric L. Eisenstein, Christopher B. Granger, Frans Van de Werf, Daniel B. Mark

    Resumen Resumen Esquema Esquema  
• • ·Clinical factors that influence response to treatment strategies in atrial fibrillation: The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study

    Página :645-649

    The AFFIRM Investigators   *

    Resumen Resumen Esquema Esquema
• • ·Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study

    Página :650-656

    John P. DiMarco, Gregory Flaker, Albert L. Waldo, Scott D. Corley, H. Leon Greene, Robert E. Safford, Lynda E. Rosenfeld, Gladys Mitrani, Margit Nemeth, The AFFIRM Investigators

    Resumen Resumen Esquema Esquema  
• • ·Asymptomatic atrial fibrillation: Demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study

    Página :657-663

    Greg C. Flaker, Kathy Belew, Karen Beckman, Humberto Vidaillet, Jack Kron, Robert Safford, Mary Mickel, Patrick Barrell, the AFFIRM Investigators 1

    Resumen Resumen Esquema Esquema  
• • ·Concerns about the implantable cardioverter defibrillator: A determinant of anxiety and depressive symptoms independent of experienced shocks

    Página :664-669

    Susanne S. Pedersen, Ron T. van Domburg, Dominic A.M.J. Theuns, Luc Jordaens, Ruud A.M. Erdman

    Resumen Resumen Esquema Esquema  
• • ·Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy

    Página :670-674

    Trip J. Meine, Sana M. Al-Khatib, John H. Alexander, Christopher B. Granger, Harvey D. White, Rakhi Kilaru, Kathryn Williams, E. Magnus Ohman, Eric Topol, Robert M. Califf

    Resumen Resumen Esquema Esquema  
• • ·The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis

    Página :675-680

    Burak Pamukcu, Huseyin Oflaz, Yilmaz Nisanci

    Resumen Resumen Esquema Esquema
• • ·Prospective randomized comparison of early and late results of a carbonized stent versus a high-grade stainless steel stent of identical design: The Prevention of Recurrent Venous Thromboembolism (PREVENT) trial

    Página :681-688

    Peter B. Sick, Oana Brosteanu, Matthias Ulrich, Holger Thiele, Josef Niebauer, Ingmar Busch, Gerhard Schuler

    Resumen Resumen Esquema Esquema  
• • ·Two-year clinical follow-up of ⁹⁰Sr/⁹⁰ Y ?-radiation versus placebo control for the treatment of in-stent restenosis

    Página :689-694

    Sigmund Silber, Jeffrey J. Popma, Mohan Suntharalingam, Alexandra J. Lansky, Richard R. Heuser, Burton Speiser, Paul S. Teirstein, Theodore Bass, William O'Neill, John Lasala, Mark Reisman, Samin K. Sharma, Richard E. Kuntz, Raoul Bonan, for the START Investigators

    Resumen Resumen Esquema Esquema  
• • ·Diabetes and progression of coronary calcium under the influence of statin therapy

    Página :695-700

    Matthew J. Budoff, Dale Yu, Khurram Nasir, Rajnish Mehrotra, Lynn Chen, Junichiro Takasu, Nisha Agrawal, Sandy T. Liu, Roger S. Blumenthal

    Resumen Resumen Esquema Esquema  
• • ·Safety and accuracy of multidetector row computed tomography for early assessment of residual stenosis of the infarct-related artery and the number of diseased vessels after acute myocardial infarction

    Página :701-708

    Kuan-Rau Chiou, Ming-Ting Wu, Shih-Hung Hsiao, Guang-Yuan Mar, Huay-Ben Pan, Chien-Fang Yang, Chun-Peng Liu

    Resumen Resumen Esquema Esquema  
• • ·Electrocardiographic diagnosis of left ventricular hypertrophy: The effect of left ventricular wall thickness, size, and mass on the specific criteria for left ventricular hypertrophy

    Página :709-714

    Navin Budhwani, Sanjeev Patel, Edward M. Dwyer

    Resumen Resumen Esquema Esquema  
• • ·Intensity and focus of heart failure disease management after hospital discharge

    Página :715-721

    Monica R. Shah, Carol M. Flavell, Joanne R. Weintraub, Michelle A. Young, Vic Hasselblad, James C. Fang, Anju Nohria, Eldrin F. Lewis, Michael M. Givertz, Gilbert Mudge, Lynne W. Stevenson

    Resumen Resumen Esquema Esquema  
• • ·Metaanalysis and review of heart failure disease management randomized controlled clinical trials

    Página :722-729

    David J. Whellan, Vic Hasselblad, Eric Peterson, Christopher M. O'Connor, Kevin A. Schulman

    Resumen Resumen Esquema Esquema  
• • ·Left atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathy

    Página :730-736

    Vandana Sachdev, Yukitaka Shizukuda, Cynthia L. Brenneman, Charles W. Birdsall, Myron A. Waclawiw, Andrew E. Arai, Saidi A. Mohiddin, Dorothy Tripodi, Lameh Fananapazir, Jonathan F. Plehn

    Resumen Resumen Esquema Esquema  
• • ·A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications

    Página :737-743

    Ali Ahmed, Robert M. Centor, Michael T. Weaver, Gilbert J. Perry

    Resumen Resumen Esquema Esquema  
• • ·Plagiarism notice

    Página :743

    Robert M. Califf, Daniel B. Mark

    
• • ·Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: A ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy

    Página :744-750

    Daniel G. Krauser, Donald M. Lloyd-Jones, Claudia U. Chae, Renee Cameron, Saif Anwaruddin, Aaron L. Baggish, Annabel Chen, Roderick Tung, James L. Januzzi

    Resumen Resumen Esquema Esquema  
• • ·Table of Contents

    Página :A2

    
• • ·Editorial Board

    Página :A6

    
• • ·Information for Authors

    Página :A7

    
• • ·Information for Readers

    Página :A10